Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...

With the readout of UNVEIL-IT® Phase 2, which evaluates VS-01, also targeted in the second half of 2025, up to 4 clinical datasets are expected to be released by GENFIT before the end of this year ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research ... during the trial, we recommend you report this transparently, with reasons. This sample size paragraph is intended to outline how ...

Jan. 27, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (Company) (Nasdaq: ALLK), today announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria (CSU).

A Peter Mac-led international clinical trial has shown adding ... dramatically improve breast cancer cure rates. The Phase III CheckMate-7FL trial involved 510 people with the "ER+/HER2-" sub ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad ...

Perioperative chemotherapy with either S-1 or 5-fluorouracil plus oxaliplatin and docetaxel for locally advanced gastric or gastroesophageal junction adenocarcinoma: A prospective trial and matched ...

Clinical trials progress through four main phases before a new treatment becomes widely available. These phases together make up the drug approval process, which ensures that new treatments are safe ...

CHICAGO, Jan 24 (Reuters) - The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a ...